This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $750 | To Be Confirmed |
250mg | $1350 | To Be Confirmed |
500mg | $2025 | To Be Confirmed |
Cat #: V21862 CAS #: 1420367-28-7 Purity ≥ 99%
Description: GSK2814338 (GSK-2814338) is a novel and potent Lp-PLA2 (Lipoprotein-associated phospholipase A2) with the potential to be used for atherosclerosis and Alzheimer's disease.
References: Zehong Wan, et al. Bicyclic pyrimidone compounds. WO2013014185A1.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 468.38 |
---|---|
Molecular Formula | C21H17F5N4O3 |
CAS No. | 1420367-28-7 |
SMILES Code | O=C1N=C(OCC2=CC(F)=C(OC3=CC=C(C(F)(F)F)N=C3)C(F)=C2)C=C4N(C)CCCN41 |
Synonyms | GSK2814338; GSK 2814338; GSK-2814338 |
Protocol | In Vitro | Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a phospholipase A2 enzyme involved in hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2 travels with low-density lipoprotein (LDL) and rapidly cleaves oxidized phosphatidylcholine molecules derived from the oxidation of LDL. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.1350 mL | 10.6751 mL | 21.3502 mL | 42.7004 mL |
5mM | 0.4270 mL | 2.1350 mL | 4.2700 mL | 8.5401 mL |
10mM | 0.2135 mL | 1.0675 mL | 2.1350 mL | 4.2700 mL |
20mM | 0.1068 mL | 0.5338 mL | 1.0675 mL | 2.1350 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.